When Raymond Starr was diagnosed with prostate cancer last year, he was refused an mpMRI on the NHS because there are no scanners available in North Wales. He's now working with us to make sure the revolutionary diagnostic technique is available to all men in the UK.
New research backed by us and the Movember Foundation has shown that a type of ultrasound scan, which can detect the stiffness of the prostate, may be able to spot aggressive cancer.
Evidence continues to mount for giving men an mpMRI scan before a prostate biopsy after an international trial of 500 men showed that mpMRI-guided biopsies help to catch more aggressive cancers and fewer harmless cancers.
This weekend, national media picked up a story that we reported in November about an NHS England scheme trialling a “one-stop-shop” process for diagnosing prostate cancer. The story was picked up from The Daily Mail, who have recently begun a prostate cancer campaign after being moved by our news that prostate cancer is now the third biggest cancer killer.
Results of a report released today have shown that the average time it takes for a man to receive a diagnosis of prostate cancer in England is 56 days following referral – far longer than the 28 day target that health officials are working towards and the average 14 day diagnosis period for breast cancer. We look into the reasons behind this dramatic difference and what is being done about it.
At a conference in London this week, Secretary of State for Health, Jeremy Hunt, announced plans to increase the number of specialists employed by the NHS to improve cancer diagnosis and care. But despite this welcome news, some important staffing shortfalls still need to be addressed.
A report released by the Royal College of Surgeons shows more men are getting an appropriate level of treatment, but issues with late diagnosis persist and uptake of mpMRI has been patchy. However, a pilot scheme also announced today offers a promising step forward.
Plans to rollout mpMRI scans before a first biopsy for all UK men suspected of prostate cancer are under threat, as long-term vacancies and increasing demand put a strain on the NHS's radiology services.
After today's confirmation that mpMRI scans before a biopsy can radically improve the accuracy of prostate cancer diagnosis, figures reveal that just 32% of eligible men currently have access to the procedure because of a shortage of scanners and qualified staff to use them in the NHS.
BLOG: Today's announcement about mpMRI scans before a biopsy is a game-changer for prostate cancer diagnosis. But without Prostate Cancer UK's funding of a pilot project in 2010 thanks to your donations, this ground-breaking research would never have happened, says Dr Ian Le Guillou.